Effectiveness of Virtual Reality (VR) in the Management of Anxiety for Patients Undergoing Radiotherapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWake Forest University Health Sciences
About this trial
The purpose of this study is to evaluate the use and functionality of virtual reality (VR) during radiation therapy treatments for patients with prostate, breast, lung, or head and neck cancer.
Eligibility criteria
Qualifiers
Participants planned for radiation therapy for 15 or more treatments with non-neutron generating energies (10 MV or less) per study PI for prostate, breast, lung, or head and neck cancer. Neutrons have the potential to damage the VR headset device and are generated for energies above 10 MV.
Age 18 years or older at the time of consent.
Eastern Cooperative Oncology Group (ECOG) performance status of 0-3 at the time of enrollment.
Ability to understand and the willingness to sign an IRB-approved informed consent document directly.
Disqualifiers
Previous radiation therapy
VR device is determined to impede the radiation dosage during the VR device simulation and treatment planning
Participants with primary brain tumors, brain metastases, and cancer involving the sinuses, orbits, nose, or ears, are excluded from this clinical trial because the VR device may obstruct the area being treated
Participants with uncontrolled inter-current illness including but not limited to psychiatric illness/social situations that would limit compliance with study requirements per treating radiation oncologist.
Trial design
Treatments tested in this trial
- standard of care
- Virtual Reality Intervention
- Radiation Therapist Survey
Treatment groups
54 Participants
are divided into 3 treatment groupsSponsors and collaborators
Wake Forest University Health Sciences
Lead sponsor
Atrium Health Wake Forest Baptist
Collaborator
Source ClinicalTrials.gov